Alberta Investment Management Corp (AIMCo)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-152,800	Closed	-$4.04M	–	1079
2019 Q1	$4.04M	Buy	152,800 +4,200	+3%	+$99.5K	0.04%	366
2018 Q4	$2.9M	Sell	148,600 -5,400	-4%	-$106K	0.03%	370
2018 Q3	$3.02M	Buy	154,000 +61,200	+66%	+$1.16M	0.03%	423
2018 Q2	$1.54M	Buy	+92,800	New	+$1.42M	0.01%	500

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s HZNP Position: Q2 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 152,800 shares — an estimated $4.04M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HZNP in Q2 2018 and held it in 4 quarters. The position peaked at $4.04M in Q1 2019. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Alberta Investment Management Corp (AIMCo) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 152,800 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $4.04M.
Alberta Investment Management Corp (AIMCo) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 4 quarters.
Alberta Investment Management Corp (AIMCo)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.04M in Q1 2019.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2019, filed 14 Aug 2019.